Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 875-892-5 | CAS number: 1375799-59-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2009-04-01 to 2009-07-10
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21 July 1997
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate
- EC Number:
- 875-892-5
- Cas Number:
- 1375799-59-9
- Molecular formula:
- C13 H14 N8 O2 . Na
- IUPAC Name:
- Sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate
Constituent 1
Method
- Target gene:
- His locus
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1537
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 1535
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 102
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 100
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- S. typhimurium TA 98
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system: S9 Liver-mix
- method of preparation of S9 mix : S9 mix was used to simulate the mammalian metabolism of the test substance. It was made from the livers of at least six adult male Sprague Dawley rats, of approximately 200 to 300 g in weight. For enzyme induction, the animals received a single intraperitoneal injection of Aroclor 1254, dissolved in corn oil, at a dose of 500 mg/kg body weight, five days prior to sacrifice. The animals were prepared unfasted, following the directions of Ames et al (1975) and Maron and Ames (1983). The rats were terminated. Livers were removed under sterile conditions immediately after sacrifice and kept at 4°C until all animals had been prepared. All the remaining steps were carried out under sterile conditions at 4°C.
The livers were washed with cold (4°C), 0.15 M KCI solution (approximately 1 mLKCI per 1 g liver), and then homogenized in fresh, cold (4°C), 0.15 M KCl (approximately 3 mL KCI per 1 g liver). The homogenate was then centrifuged in a cooling centrifuge at 4°C and 9000 g for 10 minutes. The supernatant (the S9 fraction) was stored at -80°C in small portions.
These portions were slowly thawed before use. The S9 mix was freshly prepared, kept on ice and used only on the same day. Seventy mL of cofactor solution are composed as follows:
MgCl2 x 6H2O 162.6 mg
KCl 246.0 mg
Glucose-6-phosphate (disodium salt) 179.1 mg
NADP (disodium salt) 315.0 mg
Sodium phosphate buffer (100 mM; pH 7.4) 100.0 mM
The S9 mix comprised 10% S9 fraction, 70% cofactor solution and 20% 0.15 M KCl.
The S9 fraction was derived from the preparation dated January 26, 2009 (protein content 24.4 mg per mL). Prior to first use, each batch was checked for its metabolizing capacity by using reference mutagens; appropriate activity was demonstrated. At the beginning of each experiment 4 aliquots of the S9 mix were plated (0.5 mLper plate) in order to assess its sterility. This was repeated after completion of test tube plating. The sterility control plates were then incubated for 48 hours at 37°C. No indication of contamination of S9 mix was found. - Test concentrations with justification for top dose:
- 0, 16, 50, 158, 500, 1581, 5000 µg/plate, as recommended by the OECD test guideline
Due to toxicity of the substance doses ranging from 5 to 1581 µg/plate were chosen for the repeat test. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO and water for one positive control (Mitomycin C)
- Justification for choice of solvent/vehicle: The solvent used was chosen out of the following solvents, in the order given: water, DMSO, methanol, ethanol, acetone, ethylene glycol dimethylether (EGDE), and DMF according to information given by the sponsor. The order of these solvents is based on their bacteriotoxic effects in preincubation experiments.
No "untreated" negative control was set up for the used solvent, since sufficient evidence was available in the literature (e.g. Maron and Ames, 1983) indicating that this solvent had no influence on the spontaneous mutant counts of the used strains.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- sodium azide
- cumene hydroperoxide
- mitomycin C
- other:
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments: Two
METHOD OF TREATMENT/ EXPOSURE:
- Test substance added in agar (plate incorporation); preincubation
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period, if applicable: 20 min at 37°C
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: The toxicity of the substance was assessed in three ways. The first method was a gross appraisal of background growth on the plates for mutant determination. Secondly, a toxic effect of the substance was assumed when there was a marked and dose-dependent reduction in the mutant count per plate, compared to the negative controls.
Thirdly, the titer was determined. Total bacterial counts were taken on two plates for each concentration studied with S9 mix. However, if an evaluation was performed only without S9 mix, the bacterial count was taken without S9 mix. - Rationale for test conditions:
- As recommended by OECD test guideline 471
- Evaluation criteria:
- A reproducible and dose-related increase in mutant counts of at least one strain is considered to be a positive result. For TA 1535, TA 100 and TA 98 this increase should be about twice that of negative controls, whereas for TA 1537, at least a threefold increase should be reached. For TA 102 an increase of about 100 mutants should be reached. Otherwise, the result is evaluated as negative. However, these guidelines may be overruled by good scientific judgment.
In case of questionable results, investigations should continue, possibly with modifications, until a final evaluation is possible.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity occurred from 158 µg/plate onwards
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity occurred from 158 µg/plate onwards
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity occurred from 158 µg/plate onwards
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity occurred from 158 µg/plate onwards
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- cytotoxicity occurred from 158 µg/plate onwards
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- As may be seen, there was no indication of a bacteriotoxic effect of the test item at doses of up to and including 158 μg per plate. The total bacteria counts consistently produced results comparable to the negative controls, or differed only insignificantly. No inhibition of growth was noted as well. Higher doses had a strong, strain-specific bacteriotoxic effect. Therefore they could only be used for assessment purposes up to and including 500 μg per plate.
None of the five strains concerned showed in the plate incorporation test a dose-related and
biologically relevant increase in mutant counts over those of the negative controls. This applied
both to the tests with and without S9 mix and was confirmed by the results of the preincubation trials. The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine, mitomycin C, cumene hydroperoxide and 2-aminoanthracene increased mutant counts to well over those of the negative controls, and thus demonstrated the system's sensitivity and the activity of the S9 mix.
Any other information on results incl. tables
Summary of Mean Values Without S9 Mix | |||||
Group [µg/plate] | Strain | ||||
TA1535 | TA100 | TA1537 | TA98 | TA102 | |
Plate incorporation method | |||||
0 | 7 | 98 | 6 | 16 | 205 |
16 | 6 | 122 | 6 | 16 | 211 |
50 | 7 | 121 | 6 | 15 | 240 |
158 | 5 | 112 | 4 | 12 | 115 |
500 | 4 | 100 | 2 | 19 | 105 |
1581 | 0 | 0 | 0 | 0 | 0 |
5000 | 0 | 0 | 0 | 0 | 0 |
Na-Azide | 896 |
|
|
|
|
NF |
| 314 |
|
|
|
4-NPDA |
|
| 42 | 81 |
|
MMC |
|
|
|
| 834 |
|
|
|
|
|
|
Preincubation method | |||||
0 | 7 | 123 | 5 | 22 | 226 |
5 | 6 | 114 | 6 | 17 | 251 |
16 | 7 | 116 | 5 | 24 | 248 |
50 | 8 | 123 | 6 | 18 | 195 |
158 | 6 | 127 | 6 | 23 | 204 |
500 | 8 | 111 | 6 | 25 | 178 |
1581 | 1 | 28 | 0 | 2 | 29 |
Na-Azide | 918 |
|
|
|
|
NF |
| 465 |
|
|
|
4-NPDA |
|
| 37 | 71 |
|
Cumene |
|
|
|
| 405 |
Summary of Mean Values With S9 Mix | |||||
Group [µg/plate] | Strain | ||||
TA1535 | TA100 | TA1537 | TA98 | TA102 | |
Plate incorporation method | |||||
0 | 9 | 196 | 8 | 39 | 303 |
16 | 9 | 200 | 7 | 35 | 328 |
50 | 10 | 183 | 8 | 39 | 287 |
158 | 10 | 167 | 7 | 28 | 270 |
500 | 9 | 167 | 6 | 25 | 239 |
1581 | 3 | 42 | 0 | 0 | 41 |
5000 | 0 | 0 | 0 | 0 | 0 |
2-AA | 104 | 2731 | 281 | 1902 | 686 |
|
|
|
|
|
|
Preincubation method | |||||
0 | 13 | 180 | 10 | 32 | 292 |
5 | 11 | 161 | 8 | 34 | 315 |
16 | 11 | 170 | 9 | 31 | 317 |
50 | 10 | 171 | 10 | 32 | 281 |
158 | 9 | 162 | 9 | 28 | 271 |
500 | 8 | 143 | 7 | 24 | 230 |
1581 | 4 | 42 | 0 | 3 | 152 |
2-AA | 92 | 2515 | 303 | 1786 | 553 |
Applicant's summary and conclusion
- Conclusions:
- The Salmonella/microsome test, employing doses of up to 5000 μg per plate, showed that the test item Molidustat produced bacteriotoxic effects, starting at 500 μg per plate. Therefore,
1581 μg per plate and above could not be used for assessment.
Evaluation of individual dose groups, with respect to relevant assessment parameters ( dose effect, reproducibility) revealed no biologically relevant variations from the respective negative
controls.
In spite of the low doses used, positive controls increased the mutant counts to well over those of the negative controls, and thus demonstrated the system's high sensitivity.
Despite this sensitivity, no indications of mutagenic effects of the test item could be found at assessable doses of up to 500 μg per plate in any of the Salmonella typhimurium strains used.
Due to these results Molidustat has to be regarded as non-mutagenic. - Executive summary:
In a reverse gene mutation assay in bacteria according to OECD guideline 471 (1997), Salmonella typhimurium strains TA98, TA100, TA102, TA1535,and TA1537 were exposed to Molidustat in in DMSO in concentrations of 0 (control), 16, 50, 158, 500, 1581 and 5000 µg/plate in all strains in the absence and presence of mammalian metabolic activation (rat liver S9 mix)in the plate incorporation assay. Due to the observed toxicity at > 158 µg/plate a preincubation assay was performed with 0 (control), 5, 16, 50, 158, 500 and 1581 µg/plate in the presence and absence of metabolic activation.
No precipitation was observed at any concentration. The positive controls induced the appropriate responses in the corresponding strains. The mean numbers of revertant colonies in the negative controls were within the ranges of the historical control data.
There was no evidence of an increase in the number of revertant colonies that exceeded twice background in any of the five tester strains (TA98, TA 100, TA102, TA1535, or TA1537) examined at dose levels up to 1581 µg/plate in the absence and presence of a metabolic activation source (S9). Therefore, test substance was considered to be non-genotoxic (non-mutagenic) in Salmonella tester strains TA98, TA100, TA102, TA1535, and TA 1537 under the conditions employed (plate incorporation and preincubation assay).
There was no evidence of induced mutant colonies over background.
Under the conditions of the study, the test substance was negative for mutagenic potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.